More importantly, HFn-N-PCNSs-3 resulted in the same reduction in HepG2 cell viability as N-PCNSs-3 demonstrated (Supplementary Fig. 12c), but caused little effect on the non-tumor cell line hASMC (with low expression of TfR1, Supplementary Fig. 15). This evidence concerns the gene TFRC and neoplasm.